China News Agency, Beijing, May 10 (Reporter Wang Enbo) China's National Development and Reform Commission announced the "14th Five-Year Plan for Bioeconomic Development" on the 10th.
Focusing on improving the innovation capability of the bio-economy, Wang Xiang, deputy director of the High-Tech Department of the National Development and Reform Commission, introduced that China will support leading enterprises to lead the formation of innovation consortia.
Wang Xiang said at the press conference on the same day that in recent years, the biological field has become a hot spot for investment, and biological companies account for one-third of the listed companies on the Science and Technology Innovation Board. 8%.
However, he also pointed out that the innovation and development of China's bio-economy still faces challenges such as weak original innovation capabilities.
To this end, the "Plan" adheres to the problem orientation and deploys to improve the innovation capability of the bio-economy from four aspects.
The first is to accelerate the improvement of biotechnology innovation capabilities.
Aim at key areas to implement major national science and technology projects and key R&D plans, deploy leading national major science and technology infrastructure in advance, and build a national strategic science and technology force in the biological field.
Implement the system of "revealing the list and taking command" and "horse racing", fight the battle of key core technologies, and carry out cutting-edge biotechnology innovation.
The second is to cultivate and strengthen innovative entities with strong competitiveness.
Strengthen the main body of enterprise innovation, give play to the leading and supporting role of leading enterprises, cultivate individual champions in subdivided fields, and support leading enterprises to take the lead in forming innovation consortia.
Strengthen new innovative forces, support the establishment of production-use consortia, accelerate the construction of research hospitals, clinical medical research centers and translational medical research centers, and encourage the construction of industry research institutes and innovation and development alliances.
The third is to optimize the regional layout of innovation and development.
Guide innovation resources to gather in key areas, implement special promotion actions for key industries, pilot reform measures, and create bio-economy innovation poles and bio-industry innovation highlands.
Promote the development of national biological industry bases in the direction of high-end, internationalization and platformization.
Fourth, deepen cooperation in bio-economy innovation.
Encourage domestic scientific research institutions to take the initiative to initiate and participate in major international scientific programs, encourage enterprises to speed up their integration into the international market, and promote key products to go global.
Build a biological industrial park for foreign cooperation, and explore the development and application of advanced biological therapy and diagnosis technologies in the Pilot Free Trade Zone and Hainan Free Trade Port.
(Finish)